Literature DB >> 32828729

Modulation of peroxynitrite produced via mitochondrial nitric oxide synthesis during Ca2+ and succinate-induced oxidative stress in cardiac isolated mitochondria.

Harrison J Gerdes1, Meiying Yang1, James S Heisner1, Amadou K S Camara2, David F Stowe3.   

Abstract

We hypothesized that NO• is generated in isolated cardiac mitochondria as the source for ONOO- production during oxidative stress. We monitored generation of ONOO- from guinea pig isolated cardiac mitochondria subjected to excess Ca2+ uptake before adding succinate and determined if ONOO- production was dependent on a nitric oxide synthase (NOS) located in cardiac mitochondria (mtNOS). Mitochondria were suspended in experimental buffer at pH 7.15, and treated with CaCl2 and then the complex II substrate Na-succinate, followed by menadione, a quinone redox cycler, to generate O2•-. L-tyrosine was added to the mitochondrial suspension where it is oxidized by ONOO- to form dityrosine (diTyr) in proportion to the ONOO- present. We found that exposing mitochondria to excess CaCl2 before succinate resulted in an increase in diTyr and amplex red fluorescence (H2O2) signals, indicating that mitochondrial oxidant stress, induced by elevated mtCa2+ and succinate, increased mitochondrial ONOO- production via NO• and O2•-. Changes in mitochondrial ONOO- production dependent on NOS were evidenced by using NOS inhibitors L-NAME/L-NNA, TEMPOL, a superoxide dismutase (SOD) mimetic, and PTIO, a potent global NO• scavenger. L-NAME and L-NNA decreased succinate and menadione-mediated ONOO- production, PTIO decreased production of ONOO-, and TEMPOL decreased ONOO- levels by converting more O2•- to H2O2. Electron microscopy showed immuno-gold labeled iNOS and nNOS in mitochondria isolated from cardiomyocytes and heart tissue. Western blots demonstrated iNOS and nNOS bands in total heart tissue, bands for both iNOS and nNOS in β-tubulin-free non-purified (crude) mitochondrial preparations, and a prominent iNOS band, but no nNOS band, in purified (Golgi and ER-free) mitochondria. Prior treatment of guinea pigs with lipopolysacharride (LPS) enhanced expression of iNOS in liver mitochondria but not in heart mitochondria. Our results indicate that release of ONOO- into the buffer is dependent both on O2•- released from mitochondria and NO• derived from a mtCa2+-inducible nNOS isoform, possibly attached to mitochondria, and a mtNOS isoform like iNOS that is non-inducible.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heart; Liver mitochondria; Mitochondrial oxidant stress; Nitric oxide; Nitric oxide synthase; Peroxynitrite; Superoxide

Mesh:

Substances:

Year:  2020        PMID: 32828729      PMCID: PMC7560995          DOI: 10.1016/j.bbabio.2020.148290

Source DB:  PubMed          Journal:  Biochim Biophys Acta Bioenerg        ISSN: 0005-2728            Impact factor:   3.991


  71 in total

1.  Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and association with hexokinase II in mitochondria.

Authors:  Meiying Yang; Yanji Xu; James S Heisner; Jie Sun; David F Stowe; Wai-Meng Kwok; Amadou K S Camara
Journal:  Mitochondrion       Date:  2018-11-01       Impact factor: 4.160

Review 2.  Neuronal nitric oxide synthase (nNOS) splice variant function: Insights into nitric oxide signaling from skeletal muscle.

Authors:  Jordan E Balke; Ling Zhang; Justin M Percival
Journal:  Nitric Oxide       Date:  2018-11-29       Impact factor: 4.427

3.  Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia.

Authors:  Z Lacza; M Puskar; J P Figueroa; J Zhang; N Rajapakse; D W Busija
Journal:  Free Radic Biol Med       Date:  2001-12-15       Impact factor: 7.376

4.  Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation?

Authors:  T E Bates; A Loesch; G Burnstock; J B Clark
Journal:  Biochem Biophys Res Commun       Date:  1996-01-05       Impact factor: 3.575

5.  A practical method for preparing peroxynitrite solutions of low ionic strength and free of hydrogen peroxide.

Authors:  W A Pryor; R Cueto; X Jin; W H Koppenol; M Ngu-Schwemlein; G L Squadrito; P L Uppu; R M Uppu
Journal:  Free Radic Biol Med       Date:  1995-01       Impact factor: 7.376

6.  Inhibition of peroxynitrite-induced dityrosine formation with oxidized and reduced thiols, nitric oxide donors, and purine derivatives.

Authors:  P Ferdinandy; R Schulz
Journal:  Antioxid Redox Signal       Date:  2001-02       Impact factor: 8.401

7.  Differential modulation of the cardiac L- and T-type calcium channel currents by isoflurane.

Authors:  A K Camara; Z Begic; W M Kwok; Z J Bosnjak
Journal:  Anesthesiology       Date:  2001-08       Impact factor: 7.892

Review 8.  The molecular mechanisms by which nitric oxide controls mitochondrial complex IV.

Authors:  Paolo Sarti; Marzia Arese; Alessandro Giuffrè
Journal:  Ital J Biochem       Date:  2003-03

9.  The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex.

Authors:  Stefan Dröse; Ulrich Brandt
Journal:  J Biol Chem       Date:  2008-06-03       Impact factor: 5.157

10.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.

Authors:  Edward T Chouchani; Victoria R Pell; Edoardo Gaude; Dunja Aksentijević; Stephanie Y Sundier; Ellen L Robb; Angela Logan; Sergiy M Nadtochiy; Emily N J Ord; Anthony C Smith; Filmon Eyassu; Rachel Shirley; Chou-Hui Hu; Anna J Dare; Andrew M James; Sebastian Rogatti; Richard C Hartley; Simon Eaton; Ana S H Costa; Paul S Brookes; Sean M Davidson; Michael R Duchen; Kourosh Saeb-Parsy; Michael J Shattock; Alan J Robinson; Lorraine M Work; Christian Frezza; Thomas Krieg; Michael P Murphy
Journal:  Nature       Date:  2014-11-05       Impact factor: 49.962

View more
  1 in total

Review 1.  Glutathione in Protein Redox Modulation through S-Glutathionylation and S-Nitrosylation.

Authors:  Elena Kalinina; Maria Novichkova
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.